• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Keywords » addiction

Items Tagged with 'addiction'

ARTICLES

RESEARCH UPDATE

Is Ibogaine Safe for Opioid Detox?

January 30, 2023
Richard Moldawsky, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Richard Moldawsky, MD. Dr. Moldawsky has no financial relationships with companies related to this material.

Ibogaine is being promoted as a natural and safe way to detox from
opioids. Researchers here find that ibogaine is not quite as benign as some might believe.


Read More
RESEARCH UPDATE

Driving Performance and Cannabis Users’ Perception of Safety: A Randomized Trial

January 30, 2023
Olaniyi Olayinka, MD.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Olaniyi Olayinka, MD. Dr. Olayinka has no financial relationships with companies related to this material.

Everyone knows that drinking alcohol can impair driving ability. Researchers here demonstrate that driving under the influence of cannabis can be risky as well.


Read More
RESEARCH UPDATE

Thiamine Supplementation in Patients With Alcohol Use Disorder

January 30, 2023
Peter J. Farago, MD.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Peter J. Farago, MD. Dr. Farago has no financial relationships with companies related to this material.

We review an article that examines rates of thiamine supplementation for those with alcohol use disorder in the real world. Researchers wondered, how often is thiamine supplemented properly? The answer they found: not that often.


Read More
EXPERT Q&A

Buprenorphine and Dental Issues

January 30, 2023
Talia Puzantian, PharmD, BCPP
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

 Abelleira_Headshot_CATR.jpgTalia Puzantian, PharmD, BCPP.

Deputy editor for The Carlat Addiction Treatment Report. Professor, Keck Graduate Institute School of Pharmacy. Claremont, CA.

Dr. Puzantian has no financial relationships with companies related to this material.

Buprenorphine is a first line treatment for opioid use disorder and has saved countless lives, but new warnings about associations between certain buprenorphine formulations and dental problems have people worried. Here, Dr. Puzantian reviews the data and shows us how to apply this new information to clinical care.


Read More
Ambulance_shutterstock_134436836.jpg
EXPERT Q&A

Managing Alcohol Withdrawal in the Emergency Department

January 30, 2023
Brian Fuehrlein, MD, PhD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Fuehrlein_Headshot_CATR.jpgBrian Fuehrlein, MD, PhD.

Addiction psychiatrist. Associate professor of psychiatry, Yale University. Director of the psychiatric emergency department at VA Connecticut. West Haven, CT.

Dr. Fuehrlein has no financial relationships with companies related to this material.

Alcohol withdrawal is among the most commonly encountered scenarios managed by psychiatrists in the ED. Here, Dr. Fuehrlein discusses the natural history of alcohol withdrawal, how best to assess withdrawal risk, and choose between treatment options.


Read More
CLINICAL UPDATE

What to Know About Injectable Buprenorphine (Sublocade)

January 30, 2023
Audrey Abelleira, PharmD, BCPP
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Audrey Abelleira, PharmD, BCPP. Clinical pharmacist practitioner, Pain Management and Opioid Safety Program Coordinator, VA Connecticut Healthcare System. Clinical instructor, Yale School of Medicine. New Haven, CT.

Dr. Abelleira has no financial relationships with companies related to this material.

Various formulations of buprenorphine abound, and a new long-acting injectable form (Sublocade) is one of the latest arrivals. But does it actually work? Here, we review the pharmacology behind it, go over efficacy data, and provide guidance on how to decide when to consider long-acting injectable buprenorphine for your patients.



Read More
Substance_Use_Sites.jpeg

Supervised Drug Consumption Sites

November 14, 2022
Noah Capurso, MD, MHS and Christopher Clayton, MD, EdM

Once controversial, research clearly shows the benefit of these sites, and they have started opening in the United States.


Read More
RESEARCH UPDATE

Office-Based Opioid Treatment

October 31, 2022
Joshua Blum MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Joshua Blum, MD. Dr. Blum, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Some providers may be reluctant to treat patients with opioid use disorders with MOUD, especially in a busy primary care setting, fearing that these patients are “too complex.” In this observational study, investigators found that patients on MOUD are not all that different from everyone else.


Read More
therapy_shutterstock_2067560861.png
CLINICAL UPDATE

Trauma and Addiction

October 31, 2022
Will Rutland MD, JD, MPH
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Will Rutland, MD, JD, MPH. Assistant Professor and Psychiatry Clerkship Director, UAB Heersink, School of Medicine, Montgomery Regional Campus. Montgomery, AL.    

Dr. Rutland, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Here, we describe treatment approaches for patients with comorbid addiction and PTSD.


Read More
RESEARCH UPDATE

Phenobarbital vs Lorazepam in Alcohol Withdrawal

October 31, 2022
Clayton Barnes, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Barnes Clayton, MD. Dr. Barnes, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Barbiturates and benzodiazepines are both commonly used for alcohol detoxification. But how do they compare to one another? Here, researchers found some intriguing benefits of phenobarbital.


Read More
More Articles Tagged with 'addiction'
Introducing Carlat Total Access Subscriptions

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • AUDFB1e_CoilBound_Graphic2_transparent_sm.png

    (PRE-ORDER) Treating Alcohol Use Disorder—A Fact Book (2023)

    All the tools and information needed to assess and treat your patients who are struggling with...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.